
About MP Laboratories Private Limited
Data last updated:
MP Laboratories Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24232TN2016PTC103807. Its GSTIN is 33AAKCM1306N1ZH (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Balasubramanian Umamaheswaran and Ramakrishnan Bala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.93 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹20.13 Lakh (net margin 10.4%) and EBITDA of ₹31.46 Lakh (EBITDA margin 16.3%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 16% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mplaboratories.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressSri Bala Vinayaka Plot No. 31 Door No. 3/271 Barathidasan Street Ananda Nagar Santh, Oshapuram, Chennai, Tamil Nadu, India – 600073
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of MP Laboratories Private Limited
The main business activity of MP Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of MP Laboratories Private Limited FY 2025 filings available
MP Laboratories Private Limited reported revenue of ₹1.93 Cr (up 26% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of MP Laboratories Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 26% growth in the latest year. EBITDA rose 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of MP Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹31.46 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹20.13 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of MP Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 10.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of MP Laboratories are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of MP Laboratories Private Limited
MP Laboratories Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Clan Laboratories Private Limited | ₹1.94 Cr (FY 2023) | •••• | •••• | -66.0% | •••• | Chennai, Tamil Nadu, India |
| Sendan Pharmaceuticals Private Limited | ₹1.94 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Chennai, Tamil Nadu, India |
| Adlac Life Science Private Limited | ₹1.94 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | Kalol, Gujarat, India |
| Lykmi Healthcare Private Limited | ₹1.94 Cr (FY 2024) | •••• | •••• | -18.0% | •••• | Mumbai, Maharashtra, India |
| Dashak Pharmaceuticals Private Limited | ₹1.93 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Chandigarh U.T, Chandigarh, India |
| MP Laboratories Private Limited this company | ₹1.93 Cr (FY 2024) | •••• | •••• | 26.0% | •••• | Chennai, Tamil Nadu, India |
| Medo Specia Pharma Private Limited | ₹1.92 Cr (FY 2021) | •••• | •••• | -50.0% | •••• | Mumbai, Maharashtra, India |
| Meliorate Health Private Limited | ₹1.92 Cr (FY 2023) | •••• | •••• | -7.0% | •••• | Mumbai, Maharashtra, India |
| Sreeven Pharma Private Limited | ₹1.92 Cr (FY 2025) | •••• | •••• | 284.0% | •••• | Hyderabad, Telangana, India |
| Phenomenon Nutritech Private Limited | ₹1.91 Cr (FY 2025) | •••• | •••• | 399.0% | •••• | Ahmedabad, Gujarat, India |
| Zenith Chemical Works Private Limited | ₹1.91 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below MP Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of MP Laboratories Private Limited
MP Laboratories Private Limited is audited by R RAJENDRAN & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R RAJENDRAN & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of MP Laboratories Private Limited
MP Laboratories has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Balasubramanian Umamaheswaran | Director | 25 Jan 2016 | 10 Years 8 Months | Current |
| Ramakrishnan Bala | Director | 25 Jan 2016 | 10 Years 8 Months | Current |
Ownership and Shareholding of MP Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of MP Laboratories Private Limited
MP Laboratories Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at MP Laboratories Private Limited
Employment history and EPFO contributions of people linked to MP Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on MP Laboratories Private Limited
MP Laboratories Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Balasubramanian Umamaheswaran was appointed as Director on 25 Jan 2016.
Credit Ratings, Litigation & Regulatory Alerts for MP Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by MP Laboratories Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of MP Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of MP Laboratories Private Limited
MP Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAKCM1306N1ZH | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of MP Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MP Laboratories Private Limited
MP Laboratories is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 January 2016 (10+ years old) and is registered under CIN U24232TN2016PTC103807.
MP Laboratories reported revenue of ₹1.93 Cr for FY 2024 (up 26% YoY).
MP Laboratories has 2 current directors:
- Balasubramanian Umamaheswaran - Director
- Ramakrishnan Bala - Director
MP Laboratories reported a net profit of ₹20.13 Lakh (net margin 10.4%) and EBITDA of ₹31.46 Lakh (EBITDA margin 16.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of MP Laboratories is 9% over three years and 16% over five years. In the latest year (FY 2024) revenue rose 26%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of MP Laboratories is 33AAKCM1306N1ZH, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of MP Laboratories is U24232TN2016PTC103807. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
MP Laboratories was incorporated on 25 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of MP Laboratories by revenue are Clan Laboratories Private Limited, Sendan Pharmaceuticals Private Limited, Adlac Life Science Private Limited, Lykmi Healthcare Private Limited, Dashak Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Balasubramanian Umamaheswaran was appointed as Director on 25 Jan 2016. Ramakrishnan Bala was appointed as Director on 25 Jan 2016.
MP Laboratories can be reached through the website mplaboratories.com. Its registered office is in Chennai, Tamil Nadu, India.